Rafael Muniz

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Hidradenitis Suppurativa

Drug Administration

Disease Activity

Rheumatoid Arthritis

Top Venues

Rheumatology and therapy

International journal of rheumatic diseases

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Mark C Genovese, Herbert Kellner, Yasumasa Arai, Rafael Muniz, Rieke E Alten
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies. RMD open 6 (1) (2021)
Stefan Schreiber, Katsuhiko Yamamoto, Rafael Muniz, Takafumi Iwura
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab. Pharmacology research & perspectives 8 (3) (2021)
Thomas Wj Huizinga, Yoshifumi Torii, Rafael Muniz
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity. Rheumatology and therapy 8 (1) (2020)
Rieke E Alten, Colin Markland, Malcolm Boyce, Kazuki Kawakami, Rafael Muniz, Mark C Genovese
Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis. International journal of rheumatic diseases 23 (11) (2020)